Hearken to this text

The Carina surgical robotic system. | Supply: Ronovo Surgical

Ronovo Surgical introduced in the present day that it closed a brand new spherical of financing, bringing its whole funds raised to greater than $50 million since 2020.

Shanghai-based Ronovo develops broad, cross-specialty robotic-assisted surgical procedure (RAS) expertise. LongRiver Investments led the most recent financing spherical. Current traders Lilly Asia Ventures, Vivo Capital, Matrix Companions China and GGV Capital participated. CEC Capital acted because the unique monetary advisor.

Ronovo mentioned it now exits “stealth mode,” unveiling its inaugural Carina robotic platform. Carina, a modular system constructed on proprietary expertise, allows configurable robotic help for laparoscopic surgical procedures throughout a number of specialties.

Add Ronovo to a bunch of firms, massive and small, which are looking for to tackle Intuitive within the soft-tissue robotic surgical procedure area. (Listed here are 16 surgical robotics firms you want to know.)

The corporate mentioned its oversubscribed financing spherical accelerates the multi-discipline medical trial for Carina. It additionally expects the funds to strengthen R&D and medical functions growth, in addition to bolster its expertise base.

Extra about Ronovo Surgical and its Carina system

Ronovo developed Carina in collaboration with famend Chinese language laparoscopic surgeons, in keeping with a information launch. It addresses quite a few ache factors in minimally invasive surgical procedures and gives surgeons with the pliability to decide on the perfect devices and probably the most superb anatomical entry. As such, surgeons can leverage prior laparoscopic coaching and enhance upon their surgical efficiency, the corporate mentioned.

The corporate famous that Carina minimizes tools footprint to maximise the utilization of working room area. Surgical groups can select between three-module or four-module configurations, Ronovo mentioned. Surgeons even have a full suite of devices from which to decide on with Carina.

“We’re extraordinarily grateful to our traders for his or her confidence in Ronovo’s technique to democratize robotic surgical procedure,” mentioned Dr. John Ma, founder, chair and CEO of Ronovo. “From inception, we have now stayed true to our perception that innovation should begin from an authentic pursuit to resolve precise unmet medical wants.”